Visual Training Aids

The market access training module typically provides an understanding of:

• Pricing and market access principles
• The importance of payers and Health Technology Assessments (HTA), incorporating current trends in HTA and payer evaluation criteria
• Overview of country healthcare systems, including the approaches used to price and reimburse pharmaceuticals

• We will enable learners to understand the concept of how HTA may be used to determine the price, reimbursement and/or access of a new pharmaceutical product:
  • What is a HTA?
  • Different types of HTAs globally
  • The HTA process
  • Components of an HTA submission

• How to address HTA uncertainties
• Optimizing the quality of evidence
• Manufacturer considerations
• Using real-life case studies, our HTA training program provides insights into what your organization should do to optimize HTA outcomes for your products

• Having a detailed understanding of the principles of health economic evaluation and how health economics is used by payers to determine if your product is cost-effective is essential to enable patient access
• Our health economics training provides learners with an understanding of the terminology and methodologies used within health economic analysis (e.g. what is an ICER and what is a QALY) and its importance within health technology assessments

• More advanced topics covered include health economic model designs, managing uncertainty within models and incorporating health economics into the product lifecycle, to help ensure positive outcomes

• Pharmaceutical pricing strategy is more than simply setting the price of a product in order to recover Research and Development (R&D) investments
• Developing, communicating and capturing payer value are critical during the pricing of pharmaceutical products

• Our pharmaceutical pricing training covers essential topics, such as value based pricing approaches, global pricing strategies, pricing terminology and relationship between price, volume and revenue optimization

• Understanding the pricing and reimbursement processes and stakeholder needs at a country level can facilitate market access strategy development at a local and global level

• Learn how to approach pricing and reimbursement discussions with payers to facilitate negotiations

• Understand how managed entry agreements (MEAs) can be used to facilitate patient access. The training also highlights the pros and cons of different approaches and how to implement MEAs at a local level

• Our real-world evidence training explores the fundamental principles of real world evidence for market access. This includes defining the differences between real world evidence and real-world data and understanding the benefits, limitations and current trends of using real-world evidence.

• You will gain an understanding into why payers, physicians and pharma need real world evidence and how to communicate real world evidence to each stakeholder. We will consider challenges in undertaking real world evidence analysis in practice and provide you with insight into how to incorporate real world evidence into your commercial decisions.